Neoadjuvant Cetuximab + Chemotherapy Combined With Short-course Radiotherapy

Clinical trial NCT04923620 · UNKNOWN

Trial details

NCT number: NCT04923620
Sponsor: Shanghai Minimally Invasive Surgery Center
Status: UNKNOWN
Study type: OBSERVATIONAL

Neoadjuvant Treatment Rectal Cancer Cetuximab Radiotherapy

Start date: 2021-10-20
Primary completion: 2024-08-31
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.